trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Reperfusion Injury D015427 65 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Nerve Degeneration D009410 53 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Asthma D001249 52 associated lipids
Osteosarcoma D012516 50 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Stroke D020521 32 associated lipids
Cardiomegaly D006332 31 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Endometriosis D004715 29 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Hwang DY and Ismail-Beigi F Control of Glut1 promoter activity under basal conditions and in response to hyperosmolarity: role of Sp1. 2006 Am. J. Physiol., Cell Physiol. pmid:16162661
Bell CW et al. The extracellular release of HMGB1 during apoptotic cell death. 2006 Am. J. Physiol., Cell Physiol. pmid:16855214
Zhang W and Kone BC NF-kappaB inhibits transcription of the H(+)-K(+)-ATPase alpha(2)-subunit gene: role of histone deacetylases. 2002 Am. J. Physiol. Renal Physiol. pmid:12372765
Kroening S et al. Characterization of connective tissue growth factor expression in primary cultures of human tubular epithelial cells: modulation by hypoxia. 2010 Am. J. Physiol. Renal Physiol. pmid:20032117
Yu Z and Kone BC Targeted histone H4 acetylation via phosphoinositide 3-kinase- and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells. 2006 Am. J. Physiol. Renal Physiol. pmid:16174862
Arany I et al. Restoration of CREB function ameliorates cisplatin cytotoxicity in renal tubular cells. 2008 Am. J. Physiol. Renal Physiol. pmid:18094030
Noh H et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. 2009 Am. J. Physiol. Renal Physiol. pmid:19553350
Pang M et al. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. 2009 Am. J. Physiol. Renal Physiol. pmid:19640900
Li L et al. Use of mouse hematopoietic stem and progenitor cells to treat acute kidney injury. 2012 Am. J. Physiol. Renal Physiol. pmid:21937606
Marumo T et al. Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury. 2010 Am. J. Physiol. Renal Physiol. pmid:19906951
Freidkin I et al. Effects of histone deacetylase inhibitors on rat mesangial cells. 2010 Am. J. Physiol. Renal Physiol. pmid:19923417
Dong G et al. Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells. 2010 Am. J. Physiol. Renal Physiol. pmid:19889954
Alamdari N et al. Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle. 2010 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:20538901
Yang H et al. Dexamethasone-induced protein degradation in cultured myotubes is p300/HAT dependent. 2007 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:16973938
Yang Q et al. Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: role of histone acetylation. 2012 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:23043075
Guo W et al. Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. 2009 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:19700647
Popova AP et al. Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. 2010 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:20190033
Zhang Y et al. Autophagy in pulmonary macrophages mediates lung inflammatory injury via NLRP3 inflammasome activation during mechanical ventilation. 2014 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:24838752
Kuang PP et al. Activation of elastin transcription by transforming growth factor-beta in human lung fibroblasts. 2007 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:17209135
Mizuno S et al. Inhibition of histone deacetylase causes emphysema. 2011 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:21224215
Gang H et al. Epigenetic regulation of canonical TNFα pathway by HDAC1 determines survival of cardiac myocytes. 2013 Am. J. Physiol. Heart Circ. Physiol. pmid:23585133
Davis FJ et al. Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of alpha-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15388503
Xu Q et al. Changes in cardiac Nav1.5 expression, function, and acetylation by pan-histone deacetylase inhibitors. 2016 Am. J. Physiol. Heart Circ. Physiol. pmid:27638876
Usui T et al. HDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats. 2012 Am. J. Physiol. Heart Circ. Physiol. pmid:22389387
Zhang LX et al. Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition. 2010 Am. J. Physiol. Heart Circ. Physiol. pmid:20382965
Kiela PR et al. Regulation of the rat NHE3 gene promoter by sodium butyrate. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11557515
Yang H et al. Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11208539
Gaudier E et al. Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. 2004 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:15308471
Wu JT et al. Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11171632
Pender SL et al. Butyrate upregulates stromelysin-1 production by intestinal mesenchymal cells. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11052988
Sonoyama K et al. Upregulation of activin A gene by butyrate in human colon cancer cell lines. 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12540370
Sato TA and Mitchell MD Molecular inhibition of histone deacetylation results in major enhancement of the production of IL-1beta in response to LPS. 2006 Am. J. Physiol. Endocrinol. Metab. pmid:16234266
Wang XH et al. S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer. 2010 Am. J. Pathol. pmid:20581057
Thangavel J et al. Combinatorial therapy with acetylation and methylation modifiers attenuates lung vascular hyperpermeability in endotoxemia-induced mouse inflammatory lung injury. 2014 Am. J. Pathol. pmid:24929240
Miyatake Y et al. Protective roles of epithelial cells in the survival of adult T-cell leukemia/lymphoma cells. 2013 Am. J. Pathol. pmid:23474084
Nakamura J et al. Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer. 2011 Am. J. Pathol. pmid:21281785
Moynihan AT et al. Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractility. 2008 Am. J. Obstet. Gynecol. pmid:18455134
Zhou H et al. Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies. 2006 Am. J. Hum. Genet. pmid:17033962
Lavelle D et al. Histone deacetylase inhibitors increase p21(WAF1) and induce apoptosis of human myeloma cell lines independent of decreased IL-6 receptor expression. 2001 Am. J. Hematol. pmid:11754398
Halldórsdóttir AM et al. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia. 2012 Am. J. Hematol. pmid:22374828
Atanackovic D et al. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia. 2011 Am. J. Hematol. pmid:21898529
Cho JS et al. Effects of histone deacetylase inhibitor on extracellular matrix production in human nasal polyp organ cultures. 2013 Am J Rhinol Allergy pmid:23406592
Elaut G et al. Rat hepatocyte suspensions as a suitable in vitro model for studying the biotransformation of histone deacetylase inhibitors. 2004 Altern Lab Anim pmid:23577441
Dannenberg LO et al. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation. 2006 Alcohol. Clin. Exp. Res. pmid:16737450
Agudelo M et al. Effects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA). 2011 Alcohol. Clin. Exp. Res. pmid:21447001
Agudelo M et al. Alcohol-induced serotonergic modulation: the role of histone deacetylases. 2012 Alcohol pmid:22796363
Chen G et al. [Enhancive effect of histone deacetylase inhibitor trichostatin a on transfection efficiency of adenovirus in ovarian carcinoma cell line A2780]. 2005 Ai Zheng pmid:16219132
Huang H et al. [HDAC1 expression and effect of TSA on proliferation and apoptosis of A549 cells]. 2003 Ai Zheng pmid:12969522
Zhang D et al. [Synergistic cytotoxicity effect of histone deacetylase inhibitor combined with paclitaxel on lung cancer cell lines and its mechanism]. 2009 Ai Zheng pmid:19958621
Yang YN et al. [Effects of trichostatin A and paclitaxel on apoptosis and mitochondrial membrane potential of human endometrial carcinoma Ark2 cells]. 2008 Ai Zheng pmid:18710614